146 related articles for article (PubMed ID: 27488532)
21. Overexpression of HER2/neu oncogene in pancreatic cancer correlates with shortened survival.
Lei S; Appert HE; Nakata B; Domenico DR; Kim K; Howard JM
Int J Pancreatol; 1995 Feb; 17(1):15-21. PubMed ID: 8568330
[TBL] [Abstract][Full Text] [Related]
22. [The curative surgery of periampullary tumors. The results of 48 resections].
de Almeida JC; Bettencourt A; Costa CS; de Almeida JM
Acta Med Port; 1995 Jun; 8 Suppl 1():S35-9. PubMed ID: 7653304
[TBL] [Abstract][Full Text] [Related]
23. Integrated genomic, transcriptomic, and RNA-interference analysis of genes in somatic copy number gains in pancreatic ductal adenocarcinoma.
Samuel N; Sayad A; Wilson G; Lemire M; Brown KR; Muthuswamy L; Hudson TJ; Moffat J
Pancreas; 2013 Aug; 42(6):1016-26. PubMed ID: 23851435
[TBL] [Abstract][Full Text] [Related]
24. Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer.
van der Zee JA; ten Hagen TL; Hop WC; van Dekken H; Dicheva BM; Seynhaeve AL; Koning GA; Eggermont AM; van Eijck CH
Eur J Cancer; 2010 Dec; 46(18):3393-9. PubMed ID: 20724141
[TBL] [Abstract][Full Text] [Related]
25. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
[TBL] [Abstract][Full Text] [Related]
26. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
27. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.
Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ
Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117
[TBL] [Abstract][Full Text] [Related]
28. Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma.
Schwarz RE; Keny H
Hepatogastroenterology; 2001; 48(41):1493-8. PubMed ID: 11677994
[TBL] [Abstract][Full Text] [Related]
29. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
[TBL] [Abstract][Full Text] [Related]
30. Pancreaticoduodenectomy for periampullary adenocarcinoma.
Andersen HB; Baden H; Brahe NE; Burcharth F
J Am Coll Surg; 1994 Nov; 179(5):545-52. PubMed ID: 7952456
[TBL] [Abstract][Full Text] [Related]
31. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY
J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397
[TBL] [Abstract][Full Text] [Related]
32. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of 67 pancreatic head tumors and 27 periampullary tumors].
Nobili P; Annolfi B; Crosta C; Dassi FL; Porretta T; Rovati M
Ann Ital Chir; 1993; 64(5):505-11. PubMed ID: 7912055
[TBL] [Abstract][Full Text] [Related]
34. Clinical behavior and prognostic factors of periampullary adenocarcinoma.
Chan C; Herrera MF; de la Garza L; Quintanilla-Martinez L; Vargas-Vorackova F; Richaud-Patín Y; Llorente L; Uscanga L; Robles-Diaz G; Leon E
Ann Surg; 1995 Nov; 222(5):632-7. PubMed ID: 7487210
[TBL] [Abstract][Full Text] [Related]
35. Periampullary adenocarcinoma: analysis of 5-year survivors.
Gudjonsson B
Ann Surg; 1999 Nov; 230(5):736-7. PubMed ID: 10561100
[No Abstract] [Full Text] [Related]
36. Is pancreatoduodenectomy justified for periampullary cancers with regional lymph node involvement?
Shyr YM; Su CH; Lo SS; Wang HC; Lui WY
Am Surg; 1995 Apr; 61(4):288-93. PubMed ID: 7893088
[TBL] [Abstract][Full Text] [Related]
37. Type I Interferon Receptor Expression in Human Pancreatic and Periampullary Cancer Tissue.
Booy S; Hofland LJ; Waaijers AM; Croze E; van Koetsveld PM; de Vogel L; Biermann K; van Eijck CH
Pancreas; 2015 Jan; 44(1):99-105. PubMed ID: 25072284
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA profiling in periampullary carcinoma.
Kalluri Sai Shiva UM; Kuruva MM; Mitnala S; Rupjyoti T; Guduru Venkat R; Botlagunta S; Kandagaddala R; Siddapuram SP; Sekaran A; Chemalakonda R; Rebala P; Duvvuru NR
Pancreatology; 2014; 14(1):36-47. PubMed ID: 24555977
[TBL] [Abstract][Full Text] [Related]
39. DNA aneuploidy is an independent factor of poor prognosis in pancreatic and peripancreatic cancer.
Sciallero S; Giaretti W; Geido E; Bonelli L; Zhankui L; Saccomanno S; Zeraschi E; Pugliese V
Int J Pancreatol; 1993 Aug; 14(1):21-8. PubMed ID: 8409573
[TBL] [Abstract][Full Text] [Related]
40. Prognostic implications of DNA ploidy and cell-cycle analysis in pancreatic and periampullary carcinoma.
Jorba R; Fernández-Cruz L
Hepatogastroenterology; 1994 Oct; 41(5):507-8. PubMed ID: 7851864
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
